L M Greenberger
Overview
Explore the profile of L M Greenberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Terpos E, Branagan A, Garcia-Sanz R, Trotman J, Greenberger L, Stephens D, et al.
Semin Hematol
. 2023 Apr;
60(2):107-112.
PMID: 37099029
Consensus Panel 5 (CP5) of the 11th International Workshop on Waldenstrom's Macroglobulinemia (IWWM-11; held in October 2022) was tasked with reviewing the current data on the coronavirus disease-2019 (COVID-19) prophylaxis...
2.
Morrison D, Hogan L, Condos G, Bhatla T, Germino N, Moskowitz N, et al.
Leukemia
. 2011 Aug;
26(2):271-9.
PMID: 21844871
Although the cure rate of newly diagnosed acute lymphoblastic leukemia (ALL) has improved over the past four decades, the outcome for patients who relapse remains poor. New therapies are needed...
3.
Greenberger L, Ishikawa Y
Trends Cardiovasc Med
. 2011 Jan;
4(4):193-8.
PMID: 21244886
Transporters and ion channels are highly specialized and functionally divergent molecules. However, these proteins may be less structurally diverse than previously appreciated. This is clearly apparent for one superfamily of...
4.
Zhang Y, Qu Z, Kim S, Shi V, Liao B, Kraft P, et al.
Gene Ther
. 2010 Dec;
18(4):326-33.
PMID: 21179173
Usually, small interfering RNAs and most antisense molecules need mechanical or chemical delivery methods to down-modulate the targeted mRNA. However, these delivery approaches complicate the interpretations of biological consequences. We...
5.
Sadler T, Gavriil M, Annable T, Frost P, Greenberger L, Zhang Y
Endocr Relat Cancer
. 2006 Sep;
13(3):863-73.
PMID: 16954435
The effect of combinations of a mammalian target of rapamycin (mTOR) inhibitor, temsirolimus, and an estrogen receptor-alpha (ERalpha) antagonist, ERA-923, on breast carcinoma in culture and in a xenograft model...
6.
Greenberger L, Annable T, Collins K, Komm B, Lyttle C, Miller C, et al.
Clin Cancer Res
. 2001 Oct;
7(10):3166-77.
PMID: 11595711
Purpose: Tamoxifen is an antiestrogen used in women who have estrogen receptor (ER)-alpha-positive breast cancer. Unfortunately, resistance to tamoxifen is common in women with metastatic disease and side effects, including...
7.
Tsou H, Mamuya N, Johnson B, Reich M, Gruber B, Ye F, et al.
J Med Chem
. 2001 Aug;
44(17):2719-34.
PMID: 11495584
A series of new 6-substituted-4-(3-bromophenylamino)quinazoline derivatives that may function as irreversible inhibitors of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases have been prepared....
8.
Miller C, Collini M, Tran B, Harris H, Kharode Y, Marzolf J, et al.
J Med Chem
. 2001 May;
44(11):1654-7.
PMID: 11356100
No abstract available.
9.
Wissner A, Berger D, Boschelli D, Floyd Jr M, Greenberger L, Gruber B, et al.
J Med Chem
. 2000 Sep;
43(17):3244-56.
PMID: 10966743
The synthesis and SAR of a series of 4-anilino-6, 7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor (EGF-R) kinase are described. Condensation of 3, 4-dialkoxyanilines with ethyl (ethoxymethylene)cyanoacetate followed by thermal...
10.
Rabindran S, Ross D, Doyle L, Yang W, Greenberger L
Cancer Res
. 2000 Jan;
60(1):47-50.
PMID: 10646850
Fumitremorgin C (FTC) is a potent and specific chemosensitizing agent in cell lines selected for resistance to mitoxantrone that do not overexpress P-glycoprotein or multidrug resistance protein. The gene encoding...